UBS Group AG Acquires 645,662 Shares of Clovis Oncology (NASDAQ:CLVS)
UBS Group AG lifted its holdings in Clovis Oncology (NASDAQ:CLVS – Get Rating) by 213.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 947,503 shares of the biopharmaceutical company’s stock after buying an additional 645,662 shares during the quarter. UBS Group AG owned about […]
Source: etfdailynews.com